MediWound , an Israeli developer of products to treat burns and wounds using non-surgical tissue repair, said on Wednesday it was starting a Phase III trial for its treatment for venous leg ulcers.
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...
Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closure Interim analysis planned after 65% of patients complete treatment, expected in ...
The Marion Star on MSN3h
OhioHealth Marion General to become latest hospital to offer placenta donationThe addition of Marion General means the Lifeline of Ohio Placenta Donation Program will be available at all OhioHealth ...
YAVNE, Israel - MediWound Ltd. (NASDAQ:MDWD), a biopharmaceutical company specializing in enzymatic therapies for tissue repair, has launched a Phase III clinical trial for its product EscharEx®, ...
Matthew Valentine held the TCA boys basketball career scoring record for 23 years. Brayden Waller broke it recently, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback